Reference : First Direct Assay for Intact Human Proinsulin
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/77495
First Direct Assay for Intact Human Proinsulin
English
Houssa, P. [> > > >]
Dinesen, B. [> > > >]
Deberg, Michelle mailto [Université de Liège - ULg > > Unité de recherche sur l'os et le cartillage (U.R.O.C.) >]
Frank, B. H. [> > > >]
Van Schravendijk, C. [> > > >]
Sodoyez-Goffaux, F. [> > > >]
Sodoyez, J. C. [> > > >]
Jul-1998
Clinical Chemistry
44
7
1514-9
International
0009-9147
[en] We describe a sensitive two-site sandwich enzyme-linked immunosorbent assay for the measurement of intact human proinsulin in 100 microL of serum or plasma. The assay is based on the use of two monoclonal antibodies specific for epitopes at the C-peptide/insulin A chain junction and at the insulin B chain/C-peptide junction, respectively. Cross-reactivities with insulin, C-peptide, and the four proinsulin conversion intermediates were negligible. The detection limit in buffer was 0.2 pmol/L (3 standard deviations from zero). The working range was 0.2-100 pmol/L. The mean intra- and interassay coefficients of variation were 2.4% and 8.9%, respectively. The mean recovery of added proinsulin was 103%. Dilution curves of 40 serum samples are parallel to the proinsulin calibration curve. Proinsulin concentrations in 20 fasting healthy subjects were all above the limit of detection: median (range), 2.7 pmol/L (1.1-6.9 pmol/L). Six fasting non-insulin-dependent diabetes mellitus and five insulinoma patients had proinsulin concentrations significantly higher than healthy subjects: median (range), 7.7 pmol/L (3.2-18 pmol/L) and 153 pmol/L (98-320 pmol/L), respectively.
http://hdl.handle.net/2268/77495

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Clinical chemistry 1998 PH.pdfPublisher postprint331.49 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.